Globus Medical, Inc.
GMED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,702,930 | $7,979,799 | $10,010,612 | $11,308,856 |
| - Cash | $371,769 | $229,446 | $461,266 | $784,438 |
| + Debt | $119,343 | $121,104 | $92,313 | $537,188 |
| Enterprise Value | $7,450,504 | $7,871,457 | $9,641,659 | $11,061,606 |
| Revenue | $769,048 | $745,342 | $598,121 | $657,293 |
| % Growth | 3.2% | 24.6% | -9% | – |
| Gross Profit | $486,672 | $496,577 | $402,724 | $393,856 |
| % Margin | 63.3% | 66.6% | 67.3% | 59.9% |
| EBITDA | $215,120 | $193,443 | $164,135 | $145,283 |
| % Margin | 28% | 26% | 27.4% | 22.1% |
| Net Income | $118,966 | $202,846 | $75,462 | $26,505 |
| % Margin | 15.5% | 27.2% | 12.6% | 4% |
| EPS Diluted | 0.88 | 1.49 | 0.54 | 0.19 |
| % Growth | -40.9% | 175.9% | 184.2% | – |
| Operating Cash Flow | $249,695 | $77,865 | $177,300 | $210,339 |
| Capital Expenditures | -$30,817 | -$46,562 | -$41,103 | -$17,111 |
| Free Cash Flow | $218,878 | $31,303 | $136,197 | $193,228 |